Latest Insights - page 73 | BiopharmaTrend

Xcell Biosciences and ElevateBio Forge Partnership to Enhance Cell and Gene Therapy Development

Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic partnership with ElevateBio, LLC. This collaboration is set to explore …

Continue ›››

Life Sciences & Net Zero: Charting a Sustainable Path

Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. However, healthcare alone accounts for 5% of global greenhouse gas …

Continue ›››

Enabling Pharma 4.0 Using AI: Interview With Rajiv Anand, Founder of Quartic.ai

Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly manageable with a legacy approach to pharmaceutical manufacturing. A combination …

Continue ›››

MIT Unveils Breakthrough Technique for Noninvasive RNA Expression Studies

Researchers at the Massachusetts Institute of Technology (MIT) have made significant advancement in the study of cellular processes such as cancer progression and embryonic development. This innovative method utilizes Raman spectroscopy, …

Continue ›››

Arguably, the World's First Real-time Pathogen Detection Device

In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in a pre-seed funding round. This funding was led by LocalGlobe and will …

Continue ›››

Isomorphic Labs Announces Collaborations with Eli Lilly and Novartis for AI-Driven Drug Discovery

Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly and Company and Novartis. These partnerships focus on employing artificial …

Continue ›››

Exploring a Novel Approach to Treat Primary Ciliary Dyskinesia: The RCT1100 Study

ReCode Therapeutics, a leader in genetic medicines, is pioneering a promising avenue in the treatment of primary ciliary dyskinesia (PCD) with its latest clinical trial involving RCT1100, a groundbreaking mRNA-based …

Continue ›››

9 Notable AI Companies in Clinical Research to Watch in 2023

The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even …

Continue ›››

Menarini Group and Insilico Medicine Forge Partnership for Novel Cancer Therapy Development

In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This collaboration is set to advance a novel KAT6A inhibitor, developed …

Continue ›››

C4X Discovery: Advancing Drug Discovery with NRF2 Activator Program

C4X Discovery Holdings plc (AIM: C4XD), a drug discovery company, recently announced a significant milestone in its partnership with AstraZeneca. The company received an $11 million payment, a testament to …

Continue ›››

InVivo Biosystems Raises $3M for CRISPR Research and Welcomes New Board Chairman

InVivo Biosystems, operating in the realm of CRISPR-edited animal models for biomedical research, has recently embarked on a new phase of growth and innovation. The Eugene, Oregon-based company has secured …

Continue ›››

Bioptimus: Pioneering LLMs in Biotechnology

Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated to developing a large-language model (LLM) specifically for biotechnology. This …

Continue ›››